Evelo: Flagship-backed startup Evelo, behind failed eczema drug, to dissolve
The Cambridge biotech that held two rounds of layoffs earlier this year is shutting down for good.
Read full article »
President & CEO
Balkrishan Gill
Evelo is a Massachusetts-based biotechnology company that researches and develops oral medicines for the treatment of patients with inflammatory diseases.
Read more